Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 453.36
   
  • Change Today:
    $-0.38
  • 52 Week High: $455.92
  • 52 Week Low: $451.75
  • Currency: US Dollars
  • Shares Issued: 256.94m
  • Volume: 692,968
  • Market Cap: $116,486m
  • RiskGrade: 164
  • Beta: 0.00

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 453.36
Change Today $ -0.38
% Change -0.08 %
52 Week High $455.92
52 Week Low $451.75
Volume 692,968
Shares Issued 256.94m
Market Cap $116,486m
Beta 0.00
RiskGrade 164

What The Brokers Say

Strong Buy 8
Buy 11
Neutral 9
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 31-Dec-2025

Time Volume / Share Price
15:59 90 @ $453.50
15:59 74 @ $453.35
15:59 63 @ $453.39
15:59 63 @ $453.43
15:59 40 @ $453.48

Top of Page